Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1

Journal of Medical Virology

Volumn 86, Issue 5, 2014, Pages 745-757

  Pourkarim, Mahmoud Reza ^a,b   Vergote, Valentijn ^a   Amini Bavil Olyaee, Samad ^c   Sharifi, Zohre ^b   Sijmons, Steven ^a   Lemey, Philippe ^a   Maes, Piet ^a   Alavian, Seyed Moayed ^d   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Middle East Liver Diseases Center (MELD Centers)   (Iran)

Author keywords

Full length genome; Hepatitis B virus; Iran; Persian gulf; Subgenotype; Subtype

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HBV SUBGENOTYPE D1; HBV SUBTYPE AYW1; HBV SUBTYPE AYW2; HBV SUBTYPE AYW3; HEPATITIS B VIRUS; HUMAN; IMMIGRATION; IRAN; LIVER DISEASE; MALE; MIDDLE AGED; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; SPECIES ENDEMICITY; SYRIAN ARAB REPUBLIC; TURKEY (REPUBLIC); UNINDEXED SEQUENCE; VIRUS CARRIER; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS MUTATION; VIRUS STRAIN; YOUNG ADULT;

HEPATITIS B VIRUS;

FULL-LENGTH GENOME; HEPATITIS B VIRUS; IRAN; PERSIAN GULF; SUBGENOTYPE; SUBTYPE;

ADULT; CARRIER STATE; CLUSTER ANALYSIS; DNA, VIRAL; EVOLUTION, MOLECULAR; FEMALE; GENOME, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGEOGRAPHY; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84895922140     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23864     Document Type: Article

References (93)

1. Alavian SM, Fallahian F, Lankarani KB. 2007. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16:403-406.
2. Alavian SM, Hajarizadeh B, Ahmadzadeh-Asl MAK, Bagheri-Lankarani K. 2008. Hepatitis B Virus Infection in Iran: A systematic review. Hepat Mon 8:281-294.
3. Alfaresi M, Elkoush A, Alshehhi H, Alzaabi A, Islam A. 2010. Hepatitis B virus genotypes and precore and core mutants in UAE patients. Virol J 7:160.
4. Ali MM, Hasan F, Ahmad S, Al-Nakib W. 2010. Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates. Virol J 7:111.
5. Ali A, Nisar M, Idrees M, Ahmad H, Hussain A, Rafique S, Sabri S, Rehman HU, Ali L, Wazir S, Khan T. 2012. Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan. Infect Genet Evol 12:1865-1869.
6. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, Mahboudi F. 2005. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 76:318-326.
7. Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM. 2008. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. Int J Infect Dis 12:83-87.
8. Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, Trautwein C, Tacke F. 2009. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. J Hepatol 51:647-654.
9. Amini-Bavil-Olyaee S, Maes P, Van Ranst M, Pourkarim MR. 2012. Providing strong evidence of nosocomial outbreak of hepatitis B virus infection. J Hosp Infect 80:269-270; author reply 270-262.
10. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. 2008. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis 12:387-390.
11. Bozdayi G, Turkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. 2005. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 76:476-481.
12. Carman WF. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:11-20.
13. Chang MH. 2010. Breakthrough HBV infection in vaccinated children in Taiwan: Surveillance for HBV mutants. Antivir Ther 15:463-469.
14. Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. 2002. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: Clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol 40:16-21.
15. Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E, Adeli A, Mahboudi F. 2009. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. New Microbiol 32:193-198.
16. Echevarria JM, Avellon A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78:S36-S42.
17. Echevarria JM, Avellon A, Magnius LO. 2005. Molecular epidemiology of hepatitis B virus in Spain: Identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 76:176-184.
18. Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M. 2008. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 23:474-481.
19. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. 2011. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon 11:346-350.
20. Garmiri P, Rezvan H, Abolghasemi H, Allain JP. 2011. Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol 83:948-952.
21. Gasim GI. 2013. Hepatitis B virus in the Arab world: Where do we stand? Arab J Gastroenterol 14:35-43.
22. Hakre S, Peel SA, O'Connell RJ, Sanders-Buell EE, Jagodzinski LL, Eggleston JC, Myles O, Waterman PE, McBride RH, Eader SA, Davis KW, Rentas FJ, Sateren WB, Naito NA, Tobler SK, Tovanabutra S, Petruccelli BP, McCutchan FE, Michael NL, Cersovsky SB, Scott PT. 2011. Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom. Transfusion 51:473-485.
23. Hollinger FB. 2007. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 14:11-15.
24. Hollinger FB, Bell B, Levy-Bruhl D, Shouval D, Wiersma S, Van Damme P. 2007. Hepatitis A and B vaccination and public health. J Viral Hepat 14:1-5.
25. Italiano CM, Speers DJ, Chidlow GR, Dowse GK, Robertson AG, Flexman JP. 2011. Hepatitis B outbreak following a mass-casualty incident, Australia. J Infect Dis 204:400-407.
26. Kafi-abad SA, Rezvan H, Abolghasemi H. 2009. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med 19:189-194.
27. Karimabad MN, Hassanshahi G, Gharebaghiyan A, Sharifi Z. 2012. Study of hepatitis B prevalence in parallel with the most frequent HBV genotype in South Iranian blood donors. J Clin Lab Anal 26:407-411.
28. Katoh K, Toh H. 2008. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 9:286-298.
29. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res 127:164-176.
30. Khan F, Akbar H, Idrees M, Khan H, Shahzad K, Kayani MA. 2011. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. BMC Infect Dis 11:176.
31. Kim H, Jee Y, Mun HS, Song BC, Park JH, Hyun JW, Hwang ES, Cha CY, Kook YH, Kim BJ. 2007. Comparison of full genome sequences between two hepatitis B virus strains with or without preC mutation (A1896) from a single Korean hepatocellular carcinoma patient. J Microbiol Biotechnol 17:701-704.
32. Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, Benazzouz M, Rebbani K, Brahim I, Salih Alj H, Zoulim F, Trepo C, Chemin I, Ezzikouri S, Benjelloun S. 2011. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 63:66-75.
33. Kitab B, Essaid El Feydi A, Afifi R, Trepo C, Benazzouz M, Essamri W, Zoulim F, Chemin I, Alj HS, Ezzikouri S, Benjelloun S. 2012. Variability in the precore and core promoter regions of HBV strains in Morocco: Characterization and impact on liver disease progression. PLoS ONE 7:e42891.
34. Kramvis A, Kew M, Francois G. 2005. Hepatitis B virus genotypes. Vaccine 23:2409-2423.
35. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, Kew MC. 2008. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80:27-46.
36. Lai MW, Yeh CT. 2008. The oncogenic potential of hepatitis B virus rtA181T/surface truncation mutant. Antivir Ther 13:875-879.
37. Lavanchy D. 2005. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34:S1-S3.
38. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. 2010. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. J Med Virol 82:1160-1167.
39. Lindh M, Andersson AS, Gusdal A. 1997. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175:1285-1293.
40. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
41. Lusida MI, Nugrahaputra VE, Soetjipto, Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H, 2008. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160-2166.
42. Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM. 2013. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients. Hepat Mon 13:e6712.
43. Maneshi H, Zare S, Karimi M, Hajiani GR. 2010. HBV and HCV viral markers seroperevalence in first-time healthy blood donors refered to transfusion centers of bushehr province, South of Iran (April 2004. to March 2008). Retrovirology 7(Suppl 1):151.
44. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. 2009. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622-1628.
45. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R. 2009. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: A population-based study. Arch Iran Med 12:225-231.
46. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, Rostami Nejad M, Antikchi MH, Sabahi F, Zali MR. 2008. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 14:858-866.
47. Mohebbi S, Amini-Bavil-Olyaee SNZ, Derakhshan F, Sabahi FMRAZ. 2009. An extremely aberrant subtype of hepatitis B virus genotype D in Iran. Hepat Mon 9:2.
48. Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. 2011. Hepatitis C and hepatitis B virus infection: Epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon 11:736-739.
49. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, Sabahi F, Zali MR. 2012. Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. J Med Virol 84:414-423.
50. Moradi A, Zhand S, Ghaemi A, Javid N, Tabarraei A. 2012. Mutations in the S gene region of hepatitis B virus genotype D in Golestan Province-Iran. Virus Genes 44:382-387.
51. Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D. 2011. Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon 11:200-202.
52. Mulyanto, Pancawardani P, Depamede SN, Wahyono A, Jirintai S, Nagashima S, Takahashi M, Nishizawa T, Okamoto H. 2012. Identification of four novel subgenotypes (C13-C16) and two inter-genotypic recombinants (C12/G and C13/B3) of hepatitis B virus in Papua province, Indonesia. Virus Res 163:129-140.
53. Mumtaz K, Hamid S, Ahmed S, Moatter T, Mushtaq S, Khan A, Mizokami M, Jafri W. 2011. A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in pakistan. Hepat Mon 11:14-18.
54. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M. 2012. Prevalence and risk factors of HIV, Syphilis, Hepatitis B and C among female prisoners in Isfahan, Iran. Hepat Mon 12:442-447.
55. Norder H, Courouce AM, Magnius LO. 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489-503.
56. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
57. Noroozi Karimabad M, Hassanshahi G, Arababadi MK. 2013. Controversial report regarding seroprevalence of hepatitis B and C viruses among hemodialysis patients in kerman province, South-East Iran. Hepat Mon 13:e7046.
58. Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C. 1999. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 180:1444-1451.
59. Omidkhoda A, Gharehbaghian A, Jamali M, Ahmadbeigi N, Hashemi SM, Rahimi A, Soleimani M. 2011. Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors. Hepat Mon 11:11-13.
60. Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, Hatzakis A. 2013. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology 57:908-916.
61. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. 2007. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277-285.
62. Pourkarim MR, Van Ranst M. 2011. Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon 11:783-785.
63. Pourkarim MR, Verbeeck J, Rahman M, Amini-Bavil-Olyaee S, Forier AM, Lemey P, Maes P, Van Ranst M. 2009. Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium. J Clin Virol 46:61-68.
64. Pourkarim MR, Amini-Bavil-Olyaee S, Lemey P, Maes P, Van Ranst M. 2010a. Are hepatitis B virus "subgenotypes" defined accurately? J Clin Virol 47:356-360.
65. Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, Rahman M, Maes P, Nevens F, Van Ranst M. 2010b. Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. J Med Virol 82:379-389.
66. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Maes P, Van Ranst M. 2010c. Novel hepatitis B virus subgenotype A6 in African-Belgian patients. J Clin Virol 47:93-96.
67. Pourkarim MR, Amini-Bavil-Olyaee S, Lemey P, Maes P, Van Ranst M. 2011a. HBV subgenotype misclassification expands quasi-subgenotype A3. Clin Microbiol Infect 17:947-949.
68. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M. 2011b. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: Overt and occult infection. J Med Virol 83:1876-1884.
69. Pourkarim MR, Sharifi Z, Soleimani A, Amini-Bavil-Olyaee S, Elsadek Fakhr A, Sijmons S, Vercauteren J, Karimi G, Lemey P, Maes P, Alavian SM, Van Ranst M. 2014. Evolutionary analysis of HBV "S" antigen genetic diversity in Iranian blood donors: A nationwide study. J Med Virol 86:144-155.
70. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R. 2008. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 15:753-760.
71. Purdy MA, Talekar G, Swenson P, Araujo A, Fields H. 2007. A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Intervirology 50:45-51.
72. Reuben A. 2002. The thin red line. Hepatology 36:770-773.
73. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. 2004. A web-based genotyping resource for viral sequences. Nucleic Acids Res 32:W654-W659.
74. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, Gharehbaghian A, Khosravi S, Abolghasemi H. 2012. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J 14:283-288.
75. Sallam TA, William Tong CY. 2004. African links and hepatitis B virus genotypes in the Republic of Yemen. J Med Virol 73:23-28.
76. Sendi H, Mehrab-Mohseni M, Zali MR, Norder H, Magnius LO. 2005. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 86:2451-2458.
77. Shen FC, Su IJ, Wu HC, Hsieh YH, Yao WJ, Young KC, Chang TC, Hsieh HC, Tsai HN, Huang W. 2009. A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers. J Biomed Sci 16:84.
78. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. 2006. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev 28:112-125.
79. Smolle E, Zohrer E, Bettermann K, Haybaeck J. 2012. Viral hepatitis induces hepatocellular cancer: What can we learn from epidemiology comparing iran and worldwide findings? Hepat Mon 12:e7879.
80. Tallo T, Norder H, Tefanova V, Krispin T, Priimagi L, Mukomolov S, Mikhailov M, Magnius LO. 2004. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol 74:221-227.
81. Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H. 2008. D2: Major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89:1829-1839.
82. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEG A4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599.
83. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, Lai CL, Ueda R, Mizokami M. 2006. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45:646-653.
84. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. 2009. A genetic variant of hepatitis B Virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83:10538-10547.
85. Tran TT, Trinh TN, Abe K. 2008. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82:5657-5663.
86. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. 2009. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat 16:259-264.
87. Yeh CT. 2010. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy. Antivir Ther 15:471-475.
88. Yousif M, Kramvis A. 2013. Genotype D of hepatitis B virus and its subgenotypes: An update. Hepatol Res 43:355-364.
89. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. 2012. Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman Province, South-East Iran. Hepat Mon 12:339-343.
90. Zehender G, Ebranati E, Gabanelli E, Shkjezi R, Lai A, Sorrentino C, Lo Presti A, Basho M, Bruno R, Tanzi E, Bino S, Ciccozzi M, Galli M. 2012a. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS ONE 7:e37198.
91. Zehender G, Shkjezi R, Ebranati E, Gabanelli E, Abazaj Z, Tanzi E, Kraja D, Bino S, Ciccozzi M, Galli M. 2012b. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect Genet Evol 12:291-298.
92. Zharkikh A, Li WH. 1995. Estimation of confidence in phylogeny: The complete-and-partial bootstrap technique. Mol Phylogenet Evol 4:44-63.
93. Zidan A, Scheuerlein H, Schule S, Settmacher U, Rauchfuss F. 2012. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon 12:e6894.